Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-08 20:11:01 Source:worldViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- Mother of Australian surfers killed in Mexico gives moving tribute to sons
- Brazil calls for taxing super
- Department of Conservation set to lose scientific expertise in job cuts
- Will Stonehenge lose its Unesco World Heritage status?
- Envision, Suez ink battery park partnership
- Democracy declines for 20th consecutive year, advocacy group says
- Xi Jinping China President New Year address: Taiwan reunification is an ominous warning message
- What is happening with the NZ housing market this week?
- What to know about the Penske scandal that has rocked IndyCar